+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

DelveInsight - Market Research Reports

Delve Insight authors market leading reports across the pharmaceutical and biotechnology sectors. The key findings and insights all come from regular monitoring of developments through the pharmaceutical and biotechnology sectors. These findings are then published through market forecasts, drug pipelines and drug insights, along with advice from top market analysts on how to best use this, alongside the detailed market forecasts offered by Delve Insight.

Neisseria Meningitides Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Neisseria Meningitides Meningitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Influenza Virus B Infections-Pipeline Insight, 2025 - Product Thumbnail Image

Influenza Virus B Infections-Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Encephalomyelitis - Pipeline Insight, 2025 - Product Thumbnail Image

Encephalomyelitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Borderline Personality Disorders - Pipeline Insight, 2025 - Product Thumbnail Image

Borderline Personality Disorders - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Influenza - Pipeline Insight, 2025 - Product Thumbnail Image

Influenza - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Hypertension - Pipeline Insight, 2025 - Product Thumbnail Image

Hypertension - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2025 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Eczema- Pipeline Insight, 2025 - Product Thumbnail Image

Eczema- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 250 Pages
  • Global
From
Acute Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Pain- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Centronuclear Myopathy- Pipeline Insight, 2025 - Product Thumbnail Image

Centronuclear Myopathy- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025 - Product Thumbnail Image

Ventricular Tachycardia (V-tach Or VT) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Cathepsin S Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cathepsin S Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Caspases Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspases Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025 - Product Thumbnail Image

Caspase 3 (CPP32, Apopain Or YAMA) Activators - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator